Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2023-06-20 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議現金股利配息基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from the company's CFO regarding the board resolution on the cash dividend distribution date and related details such as ex-dividend date, payment date, and record dates. It does not contain financial statements or detailed financial analysis but rather specific dividend payment information. The document length is only 729 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-06-20 Chinese
公告本公司112年股東常會通過解除董事競業禁止案
Board/Management Information Classification · 95% confidence The document is a regulatory announcement from a listed company (1734 杏輝) regarding a shareholder meeting resolution passed on 112/06/20 (Taiwan calendar year). The content details the approval of a waiver for a director to engage in competitive business activities, including voting results and specifics about the director and the competitive activity. This is a corporate governance-related announcement about board/management matters, specifically about a director's competitive activity approval by shareholders. It is not a full report, financial statement, or earnings release. It is not a proxy solicitation or voting result declaration but rather an announcement of a board/management related decision. Therefore, the best fitting category is Board/Management Information (MANG). The document length is short and focused on a management-related announcement, not a full report or regulatory filing fallback.
2023-06-20 Chinese
公告本公司112年股東常會重要決議事項
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement from a company (杏輝) about the important resolutions passed at its 2023 Annual General Meeting (股東常會). It includes approval of the 2022 earnings distribution, approval of the 2022 business report and financial statements, and other AGM-related decisions. The document is only 625 characters long and primarily reports the voting results and decisions made at the AGM. It does not contain the full annual report or detailed financial statements, but rather the official results of shareholder votes and resolutions. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-06-20 Chinese
112年5月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company 杏輝, providing data on loan balances and endorsement guarantees for the current and previous months. It contains tabular financial data but is very short (624 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure related to financial guarantees and credit exposure rather than a full financial report or announcement of a meeting or voting results. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-06-09 Chinese
112年5月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summarized revenue report for a company named 杏輝, showing monthly and cumulative net operating revenue figures with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document is very short (771 characters) and does not contain detailed financial statements or analysis, but rather a brief financial summary. It does not appear to be a full annual or interim report, nor an earnings release with highlights. It is more akin to a brief factsheet or summary of key financial data. Therefore, the best fitting category is Fund Information / Factsheet (FS).
2023-06-09 Chinese
112年05月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It lists the number of shares held, changes in holdings, and related information. This type of document is typical of disclosures related to insider share transactions or holdings by directors and executives. There is no indication of financial statements, earnings data, or management discussion. The document is not a report or announcement of voting results, nor is it a regulatory compliance filing or a presentation. The focus on personal shareholdings of directors and executives aligns with the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the best classification is Director's Dealing (DIRS).
2023-06-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.